Biopharma in Ireland: In Pursuit of Quality by Design




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Biopharma in Ireland: In Pursuit of Quality by Design
Released on: June 13, 2008. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    This regional report delivers a panel discussion—hosted by Fintan Walton—with key executives working to foster biopharma investment in Ireland and a top executive of a major pharma company that has facilities in the country.
  • Summary
  • Participants
  • Company
This regional report delivers a panel discussion—hosted by Fintan Walton—with key executives working to foster biopharma investment in Ireland and a top executive of a major pharma company that has facilities in the country. Well-known for having the lowest corporate tax in the EU, the Republic of Ireland offers much more to biotech and pharmaceutical companies operating there: a great pool of highly trained individuals coming out of university; very strong compliance standards; and a supporting environment that minimizes risk and helps expedite the process from initial research to product launch. 14 out of the top 15 pharmaceutical companies have significant manufacturing operations in Ireland and 7 out of the top 10 selling drugs in the world are manufactured there. With recent focus on expanding the research capabilities in the country, Ireland is working to integrate development and manufacturing—delivering an environment that creates a seamless process, allowing companies to bring their products more quickly and more efficiently from the clinic through to the market. It is these unified processes that will produce the “quality by design” that is becoming so important to the industry.
The Panel

Barry O’ Dowd, Senior VP, Pharmaceuticals and Biotechnology, IDA.


Matt Moran, Director, Pharma Council Ireland, IBEC.


Julie O’Neill, General Manager, Gilead Sciences Ltd.
PharmaTelevision
PharmaTelevision® is the groundbreaking online TV channel for the biopharma industry, offering daily television news, analysis and feature interviews with industry leaders. Since May 2006, it has rapidly grown and the channel now boasts a global audience of 10,000+ viewers including top industry executives.